Feasibility of Plasma-Methylated SFRP2 for Early Detection of Gastric Cancer

Gastric cancer (GC) is fifth most frequently diagnosed cancer and second leading cause of cancer in China. More than 80% of GC are diagnosed at an advanced stage due to low uptake rate of invasive screening method. The performance of methylated SFRP2 test was evaluated in 236 plasma samples, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Jin, Liu, Yi, Zhao, Guodong, Liu, Xiaoyu, Ma, Yong, Li, Hui, Li, Shiming, Zhu, Yun, Xiong, Shangmin, Zheng, Minxue, Fei, Sujuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218304/
https://www.ncbi.nlm.nih.gov/pubmed/32379490
http://dx.doi.org/10.1177/1073274820922559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218304/
https://www.ncbi.nlm.nih.gov/pubmed/32379490
http://dx.doi.org/10.1177/1073274820922559

Ejemplares similares